Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06594705 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06594705 · ClinicalTrials.gov record · last posted 2026-07-22

The JenaValve ALIGN-AR LVAD Registry

Study acronym: JENA-VAD
StatusActive, Not Recruiting
PhaseNot applicable
Started2024-12-09
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
To evaluate the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with continuous flow left ventricular assist devices (cfLVAD) and clinically significant aortic regurgitation (AR) who are indicated for TAVR

Protocol amendment history 1 change detected by DataLookout

2026-07-23
notable
Trial status changed: Recruiting → Active, Not Recruiting
Trial Details
NCT Number NCT06594705
Lead Sponsor JenaValve Technology, Inc.
Conditions Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Insufficiency, Aortic Valve Disease, Left Ventricular Dysfunction
Enrollment 50 participants
Start Date 2024-12-09
Primary Completion 2026-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-22